Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
about
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusionAnti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusionCardiovascular risk assessment in patients with retinal vein occlusionThe platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusionIs activated factor VII associated with retinal vein occlusion?beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusionMedical conditions underlying recurrence of retinal vein occlusion.Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension.Central retinal vein occlusion in people aged 40 years or less: a review of 17 patients.Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilutionThe epidemiology of retinal vein occlusion: the Beaver Dam Eye StudyTraditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis.Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities.Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.Management of retinal vein occlusion--consensus document.Central retinal vein occlusion: what's the story?Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual OutcomeDyslipidaemia and microvascular disease in the retina.Myocardial performance is impaired in patients with branch retinal vein occlusion.Plasma total homocysteine and retinal vascular disease.
P2860
Q24201821-2844E708-B9F6-4BCF-89F9-B6DE7AD0AA0EQ24234750-D9F5B165-CF44-44D0-A5E0-BC16E3D93BDFQ28193280-86C5ACE7-BEF2-4993-BE03-C5DD00B036CCQ28199545-02D88C82-88F4-47B7-864A-CB1B3EC74BA0Q28360273-91E1E4FD-C4C7-454C-ADB4-6B26484396D5Q33642438-68A3A3EB-2BF6-4BE3-A556-C737CFF1B2A8Q33644238-58A167F8-AF2E-4409-9C09-5B706E8851C8Q33647415-77B8335B-2D2F-4F25-AB9A-F302344684D1Q33647693-16FDEB66-A72F-4F80-8314-6932AB64BCFCQ33648418-36DE90D0-F9FC-4B65-B74B-5F837DC87FDDQ34162950-4AC51D5C-DB1D-482C-8493-B24798B1D5BCQ36976909-1FC05464-1D77-401A-A1AF-2E84EA411677Q37309890-320A4F5D-9FCC-42E2-8573-C1FA90A41388Q37318818-D62A16AB-B0A4-4CC0-B207-30F77D5B9F8DQ37876127-FB06EBC4-7D5C-4149-B2E9-DF5BA2AFC48AQ41625734-6E34C124-1DCD-49AB-85CC-75F02D695DC1Q41807644-B3B84EA0-2AB5-44B1-B142-25A2A57099D8Q45053159-84A68957-3F1D-470E-8EE9-9B58BCE89401Q51077009-2DBF5E71-4335-497E-BE59-60755FC8499DQ51553093-F2D97494-90F3-4D5F-9B23-099BC9F502CE
P2860
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
description
1982 nî lūn-bûn
@nan
1982 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մարտին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
@ast
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
@en
type
label
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
@ast
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
@en
prefLabel
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
@ast
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
@en
P2093
P2860
P356
P1476
Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
@en
P2093
P2860
P304
P356
10.1136/BJO.66.3.161
P407
P577
1982-03-01T00:00:00Z